Improving health and improving lives with #Pride. We wish everyone a happy #PRIDEmonth from our PRIDE Network employee resource group. #Pride2020 #CovancePotential
We’ve created COVID-19 Clinical Trial Connect in the U.S., a site to help accelerate patient recruitment for COVID19 trials by connecting people with suitable clinical studies in their area. Learn more here.
Covance is expanding its decentralized trials technology ecosystem through an alliance with Medable, Inc, a leading software provider for digital #clinicaltrials.
Paul Kirchgraber, CEO, Covance talks to WebMD about how #clinicaltrials are evolving in light of #COVID19.
LabCorp, a leading global life sciences company that is deeply integrated into guiding patient care, announced on April 21, that it has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
LabCorp and Ciox Health Enter Collaboration to Create Comprehensive U.S.-based COVID-19 Patient Data Registry
"I’m proud that our company is receiving this important recognition for the third consecutive year,” said Adam H. Schechter, president and CEO of LabCorp. “This is a reflection of our business practices to support workplace equality, but more importantly, our belief that our diverse base of mission-driven employees worldwide is core to our ability to innovate, meet customer needs, and deliver on our mission to improve health and improve lives."
Check out our new, state-of-the-art Shanghai R&amp;D Center! Our employees just celebrated the grand opening and are excited to be a part of the only contact research organization (CRO) in China that offers the comprehensive drug development services. Learn about our current job opportunities and join us: http://glassdoor.com/slink.htm?key=vM0De #CovancePotential
LabCorp and Envigo Sign Innovative Agreement to Expand Covance’s Nonclinical Drug Development Capabilities and Create Independent Research Model and Services Provider. Read more about the news here. http://glassdoor.com/slink.htm?key=vM5og